N6-(4-Hydroxybenzyl)adenosine

CAS No. 110505-75-4

N6-(4-Hydroxybenzyl)adenosine( Para-topolin riboside )

Catalog No. M26320 CAS No. 110505-75-4

N6-(4-Hydroxybenzyl)adenosine is a platelet aggregation inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 36 Get Quote
10MG 60 Get Quote
25MG 116 Get Quote
50MG 213 Get Quote
100MG 357 Get Quote
200MG 524 Get Quote
500MG 822 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    N6-(4-Hydroxybenzyl)adenosine
  • Note
    Research use only, not for human use.
  • Brief Description
    N6-(4-Hydroxybenzyl)adenosine is a platelet aggregation inhibitor.
  • Description
    N6-(4-Hydroxybenzyl)adenosine is a platelet aggregation inhibitor.(In Vitro):A few naturally occurring N(6)-substituted adenosine derivatives (cytokinin ribosides) were investigated as inhibitors of platelet aggregation induced in vitro by collagen and their activity range was demonstrated (IC50: 6.77-141 μM).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Para-topolin riboside
  • Pathway
    GPCR/G Protein
  • Target
    P2Y Receptor
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    110505-75-4
  • Formula Weight
    373.369
  • Molecular Formula
    C17H19N5O5
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : ≥ 100 mg/mL (267.84 mM)
  • SMILES
    OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cnc2c(NCc3ccc(O)cc3)ncnc12
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Ahn SY, et al. Dual?effects?of?isoflavonoids?from?Pueraria?lobata?roots?on?estrogenic?activity?and?anti-proliferation?of?MCF-7?human?breast?carcinoma?cells. Bioorg Chem.?2019 Mar;83:135-144.
molnova catalog
related products
  • Clopidogrel hydrogen...

    A thienopyridine-class antiplatelet agent that works by irreversibly inhibiting P2Y12 receptor on platelets.

  • Suramin

    An antitrypansomal drug that also possesses antitumor activity; inhibits CRL (Cullin-RING E3 ubiquitin ligases) activity by disrupting its ability to recruit Cdc34.

  • YM-254890

    YM 254890 is a selective Gq signaling inhibitor.